Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death

Background. Evidence is sparse regarding the optimal construction of regimens to treat multidrug-resistant (MDR) tuberculosis disease due to strains of Mycobacterium tuberculosis resistant to at least both isoniazid and rifampin. Given the low potency of many second-line antituberculous drugs, we hy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Infect Dis
Prif Awduron: Velásquez, Gustavo E., Becerra, Mercedes C., Gelmanova, Irina Y., Pasechnikov, Alexander D., Yedilbayev, Askar, Shin, Sonya S., Andreev, Yevgeny G., Yanova, Galina, Atwood, Sidney S., Mitnick, Carole D., Franke, Molly F., Rich, Michael L., Keshavjee, Salmaan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2014
Pynciau:
Articles and Commentaries
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305127/
https://ncbi.nlm.nih.gov/pubmed/24729493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu209
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg